Nepsis Inc. Amgen Inc Transaction History
Nepsis Inc.
- $404 Million
- Q3 2024
A detailed history of Nepsis Inc. transactions in Amgen Inc stock. As of the latest transaction made, Nepsis Inc. holds 59,715 shares of AMGN stock, worth $16.9 Million. This represents 4.77% of its overall portfolio holdings.
Number of Shares
59,715
Previous 55,980
6.67%
Holding current value
$16.9 Million
Previous $17.5 Million
10.01%
% of portfolio
4.77%
Previous 4.89%
Shares
6 transactions
Others Institutions Holding AMGN
# of Institutions
3,123Shares Held
409MCall Options Held
7.56MPut Options Held
7.2M-
Vanguard Group Inc Valley Forge, PA52.4MShares$14.8 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.29 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.16 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$4.03 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $151B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...